Article Text
Research letter
Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA
ABSTRACT
The Multi-centre Obstructive Sleep Apnoea Interventional Cardiovascular (MOSAIC) trial compared 6 months of CPAP therapy, versus no CPAP, in 391 patients with minimally symptomatic obstructive sleep apnoea (OSA). We now report some exploratory outcomes, markers of systemic inflammation (interleukin 6 (IL-6), IL-10, C reactive protein, tumour necrosis factor). We found no consistent changes (all p values >0.13).
Trial registration number: ISRCTN 34164388.
- Sleep apnoea
- Cytokine Biology
Statistics from Altmetric.com
Linked Articles
- Correction